Hempalta Corp. (CVE:HEMP – Get Free Report) Director Darren Hartley Bondar purchased 310,474 shares of the stock in a transaction that occurred on Tuesday, December 24th. The stock was acquired at an average cost of C$0.05 per share, with a total value of C$14,499.14.
Darren Hartley Bondar also recently made the following trade(s):
- On Tuesday, November 5th, Darren Hartley Bondar acquired 200,000 shares of Hempalta stock. The stock was bought at an average cost of C$0.04 per share, with a total value of C$8,000.00.
- On Monday, October 14th, Darren Hartley Bondar bought 135,000 shares of Hempalta stock. The shares were bought at an average cost of C$0.04 per share, for a total transaction of C$5,400.00.
Hempalta Price Performance
HEMP remained flat at C$0.04 during trading on Tuesday. The company had a trading volume of 536,080 shares, compared to its average volume of 121,431. The company has a current ratio of 3.99, a quick ratio of 0.88 and a debt-to-equity ratio of 28.72. The business’s 50 day moving average is C$0.04 and its 200 day moving average is C$0.11. The company has a market capitalization of C$3.80 million, a PE ratio of -0.32 and a beta of -0.10. Hempalta Corp. has a 12 month low of C$0.04 and a 12 month high of C$0.30.
Hempalta Company Profile
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.
Recommended Stories
- Five stocks we like better than Hempalta
- Consumer Staples Stocks, Explained
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- 3 Best Fintech Stocks for a Portfolio Boost
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Best Aerospace Stocks Investing
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter.